{"name":"GoodRx","slug":"goodrx","ticker":"GDRX","exchange":"NASDAQ","domain":"goodrx.com","description":"GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx compares prescription drug prices at more than 75,000 pharmacies in the United States. The platform allows users to consult a doctor online and obtain a prescription for certain types of medications.","hq":"Santa Monica, CA","founded":0,"employees":"697","ceo":"Scott Wagner","sector":"Digital Health / Rx Savings","stockPrice":2.5,"stockChange":-0.11,"stockChangePercent":-4.21,"marketCap":"$848M","metrics":{"revenue":796853000,"revenueGrowth":-4.4,"grossMargin":91.8,"rdSpend":121026000,"netIncome":30439000,"cash":235710000,"dividendYield":0,"peRatio":41.8,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-06-01","label":"Lipitor patent cliff ($10.8B at risk)","drug":"Lipitor","type":"patent_expiry","sentiment":"negative"},{"date":"2020-06-01","label":"Viagra patent cliff ($0 at risk)","drug":"Viagra","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"GoodRx Reports Q4 2023 Earnings","summary":"GoodRx reported Q4 2023 earnings, with revenue of $1.1B and a net loss of $0.2B.","drugName":"","sentiment":"neutral"},{"date":"2023-12-14","type":"deal","headline":"GoodRx Partners with CVS Health","summary":"GoodRx partnered with CVS Health to offer discounted prescription medications to CVS customers.","drugName":"","sentiment":"positive"},{"date":"2023-09-12","type":"regulatory","headline":"GoodRx Receives FDA Clearance for Telehealth Platform","summary":"GoodRx received FDA clearance for its telehealth platform, allowing the company to expand its services to include virtual consultations.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-04-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-18","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-01","type":"pipeline","source":"simplywall.st","summary":"Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits? - simplywall.st","headline":"Is GoodRx (GDRX) Using Employer Direct to Redefine Its Role in Workplace Drug Benefits?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNeUNRUGM2U1JkTTFraUJ1WThhOUZZb1ZiVzg1OWtGNzgyMHRhcWU1YWZLLWZ6Zzk1RkhqQk5mQ2Y4eUM1SkZadldveUlkZTc0bWdMZGFZQnM2Y1RLbDBNMGN0ck5aWjFwMGFsNzluYVNnTkR5dVg5TC1JZDcybnJSVHRVRHhENmJNaXJsdlpCSU1EYTZrVFFoTEVYZDBJcWd4RUhsSXhCdG92MU5hWWZJSkhhWlZyVFJxQnF3ZEQ4WWg?oc=5","date":"2026-02-27","type":"pipeline","source":"Investing.com South Africa","summary":"Raymond James cuts GoodRx stock price target on pharma headwinds By Investing.com - Investing.com South Africa","headline":"Raymond James cuts GoodRx stock price target on pharma headwinds By Investing.com","sentiment":"neutral"},{"date":"2026-02-27","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1IY3pSd3JqSUxGYUJUTVFQejczOV9SVmo5dUVZaktIdm9NRXVzYXZocFpqaHNMb2EtUi01d2NCSzdxTl8tTFI0bU9LMjROSnI5Vk9CVkxCZXg5VGliWHNCUU0tMkVVNDdkZV9Ja01CaGxkMzk1U3FCeTFSZGM?oc=5","date":"2026-02-26","type":"earnings","source":"AOL.com","summary":"GoodRx (GDRX) Q4 2025 Earnings Call Transcript - AOL.com","headline":"GoodRx (GDRX) Q4 2025 Earnings Call Transcript","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQelRqTnNaMnJfQURqaUhSczV5ZU1rT21KV1dwdVc2U0hZUF9oQTZjNFA5aG9YeGFRZll4TXYyeVc3cDh2NnllWWo4M3pUTW9MbHdRRXIwOW92NWh0VGFMdEg4MmZmNjQ0WjE5SC1LOE83NXJFVlVvUmZhUFE1anoyd0EzeGkyeXRXeDl1a0ZkTzVoQWtrd1J4N3Y0N09PdGtITmVrR3V3MXJtbHN1U3RDTEtKYkJnbG42NjMw?oc=5","date":"2026-02-05","type":"pipeline","source":"Business Wire","summary":"GoodRx Powers Pricing for Leading Brand Medications on TrumpRx - Business Wire","headline":"GoodRx Powers Pricing for Leading Brand Medications on TrumpRx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOV3E1ZkppTzNueGZNR1hXckR3WG1fLXVNRS1DeTNQLXZ0X2hRejdnTHJlam5KaEJpVnNiN3dGVklfaldSc0tzM1U3YXVyaWg0U3Bqdk5BOTBNeTAwYmIwNUM5SEFsZHFTS0NKYmNLcU41aFNhNVpBN2tUOXlyN0JLaFg2QVlQbGU4QXlPbkFZcjZYWXFZZDJfMDl0Uy1FV1ZRVU15Z2J0eHBSVjJaN0N5Y0tsZnlNZkRZUGpzYU1HeEtGN3JsY29XdmUtbkJ0b1dOZVBvMw?oc=5","date":"2026-02-02","type":"deal","source":"Investing.com","summary":"60 Degrees Pharmaceuticals stock falls after GoodRx partnership announcement - Investing.com","headline":"60 Degrees Pharmaceuticals stock falls after GoodRx partnership announcement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQcEdEaWtqWFc2VEZkcVhQQVFmbHl2UExtZVktdGIyU3FJQ2J0NWUtRXN4d1YwS3Z0RVhIZFBmN2J3N2pXdFFOWHZ6Rl9xM28zVkROYTEwd2U5a3MtSkpYcVZ5Wk9mVU9nUlZCSkUzaFI2dTJTVEtkNUZBNHp6RXI5STFuMjQyb3N1TDlUYlhCVkgzYVo4SUZzZHN6UzNienBPRTN5amd1bldCRVlzb003YWZDWkNMUkpZNlE?oc=5","date":"2025-11-28","type":"pipeline","source":"TradingView","summary":"HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? - TradingView","headline":"HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQNWt1aW1iQWZMNkJHbEdmNlNjVjZLemszeTNvdlM2M2ptRlpJdXVxcjQ4VEJHYmRtNFhQYU42MEJpR0IxZXFnVmJZczZYaGMzX2xleGxCMTVqcDJubWpQUUdNVS1PeG5CZVl1OGd4UEVwNmhRMmtveFNGckNwWVZOaC1HMkVpZw?oc=5","date":"2025-10-18","type":"pipeline","source":"The Motley Fool","summary":"How Does GoodRx Make Money? - The Motley Fool","headline":"How Does GoodRx Make Money?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNcVNBMFdwNlNMTHFScHptYW53clkyaFBVNlB5Q3dFeW1BVGpYSHJNbnhHaTRBcjRyVFRiVzVtYW9hNVl3elk4dkZFZmxtVm9ZLVZZQkw5cTNsMFJ0QXhzd2ZvOWJHMDFMaVY1VFltU3d2M2hLSXFybHNONjRRbF9TamZEckNnMko2SVhCNTFvZlBzaW41XzJBQVg0TlBQMV9sWDZIcWNZaGxvT0Mxam52amtaLWlyLUcyLUFsXw?oc=5","date":"2025-10-10","type":"pipeline","source":"reuters.com","summary":"Exclusive: US pharmacies, drug discounters are discussing TrumpRx role with administration - reuters.com","headline":"Exclusive: US pharmacies, drug discounters are discussing TrumpRx role with administration","sentiment":"neutral"}],"patents":[{"drugName":"Viagra","drugSlug":"sildenafil","patentNumber":"","type":"Patent Cliff","expiryDate":"2020-06-01","territory":"US","annualRevenue":0},{"drugName":"Lipitor","drugSlug":"atorvastatin","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":10800000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["RxSaver"," Blink Health","WellRx"],"therapeuticFocus":["Cardiovascular","Neurology"],"financials":{"source":"sec_edgar+yahoo","revenue":796853000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":796853000,"period":"2025-12-31"},{"value":792324000,"period":"2024-12-31"},{"value":792324000,"period":"2024-12-31"},{"value":750265000,"period":"2023-12-31"},{"value":750265000,"period":"2023-12-31"}],"grossProfit":739256000,"grossProfitHistory":[{"period":"2025-12-31","value":739256000},{"period":"2024-12-31","value":744109000},{"period":"2023-12-31","value":683340000},{"period":"2022-12-31","value":701475000}],"rdSpend":121026000,"rdSpendHistory":[{"period":"2025-12-31","value":121026000},{"period":"2024-12-31","value":123749000},{"period":"2023-12-31","value":135836000},{"period":"2022-12-31","value":143137000}],"sgaSpend":445520000,"operatingIncome":87492000,"operatingIncomeHistory":[{"period":"2025-12-31","value":87492000},{"period":"2024-12-31","value":65846000},{"period":"2023-12-31","value":-27007000},{"period":"2022-12-31","value":1738000}],"netIncome":30439000,"netIncomeHistory":[{"period":"2025-12-31","value":30439000},{"period":"2024-12-31","value":16390000},{"period":"2023-12-31","value":-8868000},{"period":"2022-12-31","value":-32828000}],"eps":0.09,"epsHistory":[{"period":"2025-12-31","value":0.09},{"period":"2024-12-31","value":0.04},{"period":"2023-12-31","value":-0.02},{"period":"2022-12-31","value":-0.08}],"cash":261820000,"cashHistory":[{"period":"2025-12-31","value":261820000},{"period":"2024-12-31","value":448346000},{"period":"2023-12-31","value":672296000},{"period":"2022-12-31","value":757165000}],"totalAssets":1404058000,"totalLiabilities":787796000,"totalDebt":542806000,"equity":616262000,"operatingCashflow":167904000,"operatingCashflowHistory":[{"period":"2025-12-31","value":167904000},{"period":"2024-12-31","value":183892000},{"period":"2023-12-31","value":138292000},{"period":"2022-12-31","value":146780000}],"capex":-74020000,"capexHistory":[{"period":"2025-12-31","value":-74020000},{"period":"2024-12-31","value":-70347000},{"period":"2023-12-31","value":-55766000},{"period":"2022-12-31","value":-55214000}],"freeCashflow":93884000,"dividendsPaid":null,"buybacks":-216372000,"employees":697,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":102553000,"ebit":24596000,"ebitda":47742000,"period":"2025-12-31","revenue":194785000,"epsBasic":0.02,"netIncome":5425000,"rdExpense":28939000,"epsDiluted":0.02,"grossProfit":177321000,"operatingIncome":22683000},{"sga":115546000,"ebit":16929000,"ebitda":38360000,"period":"2025-09-30","revenue":196028000,"epsBasic":0,"netIncome":1119000,"rdExpense":31012000,"epsDiluted":0,"grossProfit":182609000,"operatingIncome":14620000},{"sga":113249000,"ebit":30306000,"ebitda":50035000,"period":"2025-06-30","revenue":203070000,"epsBasic":0.04,"netIncome":12843000,"rdExpense":29933000,"epsDiluted":0.04,"grossProfit":189720000,"operatingIncome":26809000},{"sga":114172000,"ebit":27312000,"ebitda":48224000,"period":"2025-03-31","revenue":202970000,"epsBasic":0.03,"netIncome":11052000,"rdExpense":31142000,"epsDiluted":0.03,"grossProfit":189606000,"operatingIncome":23380000},{"sga":117375000,"ebit":22767000,"ebitda":41863000,"period":"2024-12-31","revenue":198583000,"epsBasic":0.02,"netIncome":6740000,"rdExpense":31739000,"epsDiluted":0.02,"grossProfit":186390000,"operatingIncome":18180000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":2.5,"previousClose":2.61,"fiftyTwoWeekHigh":5.81,"fiftyTwoWeekLow":1.77,"fiftyTwoWeekRange":"1.77 - 5.81","fiftyDayAverage":2.28,"twoHundredDayAverage":3.07,"beta":1.55,"enterpriseValue":1189583744,"forwardPE":6.9,"priceToBook":1.39,"priceToSales":1.08,"enterpriseToRevenue":1.51,"enterpriseToEbitda":10.87,"pegRatio":0,"ebitda":109413000,"ebitdaMargin":13.9,"freeCashflow":84616376,"operatingCashflow":170328992,"totalDebt":541350976,"debtToEquity":87,"currentRatio":1.47,"returnOnAssets":3.5,"returnOnEquity":3.2,"analystRating":"2.5 - Hold","recommendationKey":"hold","numberOfAnalysts":13,"targetMeanPrice":3.1,"targetHighPrice":4,"targetLowPrice":2,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":13,"institutionHeldPercent":60.4,"sharesOutstanding":104711186,"floatShares":91438964,"sharesShort":7617387,"shortRatio":6.03,"shortPercentOfFloat":2.2,"epsTrailing":0.06,"epsForward":0.36,"revenuePerShare":2.27,"bookValue":1.81,"officers":[{"age":52,"name":"Ms. Wendy  Barnes","title":"President, CEO & Director"},{"age":54,"name":"Mr. Douglas Joseph Hirsch","title":"Co-founder & Director"},{"age":54,"name":"Mr. Christopher A. McGinnis","title":"CFO & Treasurer"},{"age":38,"name":"Mr. Romin  Nabiey","title":"Executive Officer"},{"age":null,"name":"Mr. Justin  Fengler","title":"Chief Strategy & Operations Officer"},{"age":null,"name":"Mr. Nitin  Shingate","title":"Chief Technology Officer"},{"age":null,"name":"Ms. Aubrey  Reynolds","title":"Director of Investor Relations"},{"age":null,"name":"Ms. Gracye  Cheng","title":"Senior VP, General Counsel & Secretary"}],"industry":"Health Information Services","irWebsite":"","website":"https://www.goodrx.com","phone":"855 268 2822"}}